Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Mai 2020 08:00 ET | Quelle: Conatus Pharmaceuticals Inc.

Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split

SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that Institutional Shareholder Services Inc. (ISS) and Glass Lewis, two leading independent...
14. Mai 2020 08:00 ET | Quelle: Conatus Pharmaceuticals Inc.; Histogen Inc.

Histogen Publishes Preclinical Data on its HST 004 Spinal Disc Program

SAN DIEGO, May 14, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today the...
11. Mai 2020 08:00 ET | Quelle: Conatus Pharmaceuticals Inc.; Histogen Inc.

Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic Alopecia

SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today that...
07. Mai 2020 16:05 ET | Quelle: Conatus Pharmaceuticals Inc.

The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reconvene on May 21, 2020

SAN DIEGO, May 07, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today convened and adjourned its special meeting of stockholders in order to obtain a quorum and specific...
01. Mai 2020 16:05 ET | Quelle: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process Update

SAN DIEGO, May 01, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced financial results for the first quarter ended March 31, 2020 and provided an update on its...
20. April 2020 08:00 ET | Quelle: Conatus Pharmaceuticals Inc.

Histogen Announces Investigational Device Exemption Application for HST 002

SAN DIEGO, April 20, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today that...
15. April 2020 08:00 ET | Quelle: Conatus Pharmaceuticals Inc.; Histogen Inc.

Histogen Publishes New Preclinical Data on its HST 003 Orthopedic Program

SAN DIEGO, April 15, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today the...
06. April 2020 08:00 ET | Quelle: Conatus Pharmaceuticals Inc.; Histogen Inc.

Histogen Announces Investigational New Drug Application Amendment for HST 001

SAN DIEGO, April 06, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today that...
11. März 2020 16:45 ET | Quelle: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Reports 2019 Financial Results and Strategic Process Update

SAN DIEGO, March 11, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced financial results for the fourth quarter and full year ended December 31, 2019, and provided...
28. Januar 2020 16:05 ET | Quelle: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals and Histogen Enter into Definitive Merger Agreement

Proposed Merger Creates Regenerative Medicine Company with Three Clinical-stage Product Candidates and Combined Company Capitalization Expected to Support Operations into 2021 Companies to Hold a...

Nächste Seite